SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- October 11, 2006 -- Bioxel Pharma Inc.(TSX VENTURE: BIP), a leading manufacturer and supplier of taxane APIs and developer of targeted oncology drugs, is pleased to announce the filing of a patent application on a pharmaceutical technology designed to improve transport and tumor targeting of anticancer drugs.
